文献速递免疫规划传染病防控与疫情报告

基因修饰活疫苗对蜱传查菲埃立克体感染可诱导持久免疫应答

Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine.
PubMed 文献 · Vaccine · 2025-01-17

研究评估基因修饰活疫苗(MLAV)在犬体内诱导的免疫持续时间,疫苗接种后4、8、12个月经蜱传播攻击野生型查菲埃立克体。未接种对照组在感染后一个月评估期内感染率更高,而MLAV免疫犬迅速清除感染且全身性细菌感染显著更少,特异性IgG和CD4 T细胞应答持续存在。

要点

  • MLAV免疫犬在蜱传攻击后迅速清除查菲埃立克体感染。
  • 与未接种对照相比,MLAV免疫犬全身性细菌感染显著更少。
  • 查菲埃立克体特异性IgG和CD4 T细胞应答在整个一年评估期内持续存在。

核心结论

  • MLAV可为自然宿主提供针对蜱传查菲埃立克体感染长达一年的保护。

研究设计与样本

  • 对犬接种MLAV后,在接种后4、8、12个月经蜱传播攻击野生型查菲埃立克体,并设未接种对照。

主要发现

  • 未接种对照组在感染后一个月评估期内感染率更高。
  • MLAV免疫犬迅速清除感染,且与未接种对照相比全身性细菌感染显著更少。
  • 查菲埃立克体特异性IgG和CD4 T细胞应答在整个评估期内持续存在。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ehrlichia chaffeensis, a tick transmitted rickettsial bacterium, causes monocytic ehrlichiosis in humans and dogs. Earlier, we demonstrated that dogs immunized with a mutant strain of E. chaffeensis having a functional disruption in the gene encoding the phage head-to-tail connector protein serves as a modified live vaccine (MLAV) capable of inducing immunity against intravenous and tick-transmitted infection challenges within one month of vaccination. In this follow-up investigation, we assessed the duration of MLAV-induced immunity for one-year period against tick-transmission infection challenge. Dogs vaccinated with the MLAV were subsequently exposed to wild-type E. chaffeensis via tick transmission at 4-, 8-, and 12-months post-vaccination. Unvaccinated controls showed higher infection rates during the one-month assessment following infection. In contrast, MLAV-immunized dogs rapidly cleared infections and exhibited significantly fewer systemic bacterial infections compared to unvaccinated controls. Robust E. chaffeensis-specific IgG and CD4 T-cell responses persisted throughout the assessment period. Our findings underscore the efficacy of MLAV in providing natural hosts with protection against E. chaffeensis infection for up to one year following infected tick exposure.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Madesh S, McGill J, Jaworski DC, et al. Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine. Vaccine. 2025. PMID: 39826432. doi:10.1016/j.vaccine.2025.126730

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。